Display options
Share it on

Acta Cardiol Sin. 2013 Jan;29(1):37-48.

Baseline Serum Aldosterone-to-Renin Ratio is Associated with the Add-on Effect of Thiazide Diuretics in Non-Diabetic Essential Hypertensives.

Acta Cardiologica Sinica

Chin-Chou Huang, Hsin-Bang Leu, Po-Hsun Huang, Tao-Cheng Wu, Shing-Jong Lin, Jaw-Wen Chen

Affiliations

  1. Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan; ; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan; ; Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan;
  2. Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ; Healthcare and Management Center, Taipei Veterans General Hospital, Taipei, Taiwan; ; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan; ; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
  3. Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan; ; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
  4. Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan; ; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan; ; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

PMID: 27122683 PMCID: PMC4804959

Abstract

BACKGROUND: The baseline status of renin-angiotensin-aldosterone system (RAAS) might modify the blood pressure (BP) lowering effects of thiazide diuretics. This study aimed to determine if baseline RAAS indicated by serum aldosterone-to-renin ratio (ARR) could be associated with the add-on effects of thiazide on BP lowering in patients with other concomitant antihypertensive medication.

METHODS: Non-diabetic hypertensive patients, either untreated or unsatisfactorily treated, were enrolled if their office systolic BP was ≥ 140 or diastolic BP ≥ 90 mmHg. After 2 weeks of diet control and lifestyle modification, patients with persistently elevated BP were prospectively given hydrochlorothiazide 50 mg daily for 2 weeks. Serum aldosterone-to-renin ratio (ARR) was determined before thiazide treatment. Patients with a significant (≥ 10%) reduction of office mean artery pressure (MAP) by thiazide treatment were defined as responders.

RESULTS: Among the 66 patients studied, 27 were defined as responders after a 2-week hydrochlorothiazide treatment. Baseline serum renin level was reduced and ARR increased (p = 0.009) in the responders as compared with the non-responders. A similar pattern was also apparent in patients with or without concomitant medications. Furthermore, baseline renin level was inversely and ARR positively correlated to the MAP reduction both in the whole patient group and in patients with concomitant medications. By stepwise multiple linear regression analysis, ARR was the only independent predictor for the response to thiazide treatment (β = 0.051, p = 0.007).

CONCLUSIONS: Baseline ARR could be associated with the add-on effects of hydrochlorothiazide on BP reduction in patients with other concomitant antihypertensive treatment.

KEY WORDS: Add-on; Aldosterone-to-renin ratio; Blood pressure; Hydrochlorothiazide; Hypertension; Renin; Thiazide.

References

  1. N Engl J Med. 1972 Mar 2;286(9):441-9 - PubMed
  2. J Hum Hypertens. 2001 Feb;15(2):119-23 - PubMed
  3. N Engl J Med. 1976 Jul 8;295(2):68-73 - PubMed
  4. JAMA. 1991 Jun 26;265(24):3255-64 - PubMed
  5. Hypertension. 2002 May;39(5):996-9 - PubMed
  6. Hypertension. 1988 Sep;12(3):244-50 - PubMed
  7. Circulation. 2000 Feb 1;101(4):378-84 - PubMed
  8. Circulation. 2007 Jul 17;116(3):268-75 - PubMed
  9. JAMA. 2002 Dec 18;288(23):2981-97 - PubMed
  10. Lancet. 1999 Jan 2;353(9146):40 - PubMed
  11. J Hypertens Suppl. 1985 Dec;3(3):S275-8 - PubMed
  12. Am J Hypertens. 1998 Jul;11(7):894-6 - PubMed
  13. N Engl J Med. 1993 Apr 1;328(13):914-21 - PubMed
  14. Hypertension. 2007 Apr;49(4):846-56 - PubMed
  15. Am J Cardiol. 1991 Jan 1;67(1):67-73 - PubMed
  16. N Engl J Med. 1972 Dec 14;287(24):1209-14 - PubMed
  17. J Hypertens. 2010 Jan;28(1):170-7 - PubMed
  18. JAMA. 1993 Aug 11;270(6):713-24 - PubMed
  19. J Hypertens. 2010 Nov;28(11):2329-35 - PubMed
  20. JAMA. 1998 Oct 7;280(13):1168-72 - PubMed
  21. Br J Clin Pharmacol. 1999 Nov;48(5):756-60 - PubMed
  22. N Engl J Med. 1991 Apr 18;324(16):1098-104 - PubMed
  23. Hypertension. 1990 Nov;16(5):564-72 - PubMed
  24. Am J Hypertens. 2005 Dec;18(12 Pt 1):1631-5 - PubMed
  25. Am J Hypertens. 2005 May;18(5 Pt 1):657-65 - PubMed
  26. N Engl J Med. 2004 Jul 1;351(1):33-41 - PubMed
  27. J Hum Hypertens. 2002 Mar;16(3):159-62 - PubMed
  28. Hypertension. 1988 Sep;12(3):223-6 - PubMed
  29. Am J Med. 1983 Jun;74(6):1029-41 - PubMed
  30. JAMA. 2003 May 21;289(19):2560-72 - PubMed
  31. Kidney Int. 2002 Mar;61(3):1047-55 - PubMed
  32. Am J Hypertens. 2005 Jan;18(1):50-5 - PubMed
  33. J Hypertens. 2004 Feb;22(2):377-81 - PubMed
  34. J Hypertens. 2003 Nov;21(11):1983-92 - PubMed

Publication Types